Galmed Pharmaceuticals (GLMD) Return on Invested Capital (2016 - 2018)

Galmed Pharmaceuticals' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q4 2018.

• In Q4 2018, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Dec 2018 stood at 0.0% (changed N/A YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.0% for Q4 2018 at Galmed Pharmaceuticals, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q2 2017 to a low of 0.0% in Q3 2018.
• Historically, Return on Invested Capital has averaged 0.01% across 3 years, with a median of 0.01% in 2016.
• Biggest YoY gain for Return on Invested Capital was 2 bps in 2018; the steepest drop was 2 bps in 2018.
• A 3-year view of Return on Invested Capital shows it stood at 0.01% in 2016, then soared by 57 bps to 0.02% in 2017, then tumbled by 95 bps to 0.0% in 2018.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2018), 0.0% (Q3 2018), and 0.0% (Q2 2018), per Business Quant data.